EUVIMEDEUVIMED entdecken
Crossref

Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression

Rachel S van Leeuwaarde, Thorvardur R Halfdanarson, Shwetha M Sudhakar, Ruud W J Meijers, Andrew L Folpe, Lodewijk A A Brosens

Familial Cancer · 2025-03 · 24 (1)

DOI: 10.1007/s10689-024-00433-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 28.11.2024. Verfasst von Rachel S van Leeuwaarde und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands. r.vanleeuwaarde@umcutrech…. Hauptthemen laut MEDLINE: Loss of Heterozygosity, Multiple Endocrine Neoplasia Type 1, Proto-Oncogene Proteins, Sarcoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple endocrine neoplasia type 1 (MEN1) is a hereditary tumor syndrome characterized by endocrine tumors, typically from parathyroid, pancreatic, or anterior pituitary origin. In addition, benign cutaneous soft tissue tumors are prevalent in MEN1 patients. Although sarcomas have been reported in MEN1 patients it is unclear if these tumors should be considered as part of the MEN1 syndrome. Here, five patients with a MEN1 syndrome and a sarcoma are described. In all five sarcomas loss of heterozygosity of the MEN1 gene and loss of expression of menin are shown, suggesting that sarcomas may be a phenotypic expression of MEN1 syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Loss of HeterozygosityMultiple Endocrine Neoplasia Type 1Proto-Oncogene ProteinsSarcomaHumans

Stichwörter der Autor:innen

MEN1 geneMultiple Endocrine Neoplasia Type 1Sarcoma

Substanzen

MEN1 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands. r.vanleeuwaarde@umcutrecht.nl.
  • Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Department of Endocrine Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Department of Pathology, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.

Zitieren

APA

van Leeuwaarde, R. S., Halfdanarson, T. R., Sudhakar, S. M., Meijers, R. W. J., Folpe, A. L., & Brosens, L. A. A. (2025). Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression. Familial Cancer, 24(1). https://doi.org/10.1007/s10689-024-00433-9

Vancouver

van Leeuwaarde RS, Halfdanarson TR, Sudhakar SM, Meijers RWJ, Folpe AL, Brosens LAA. Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression. Familial Cancer. 2025;24(1). doi:10.1007/s10689-024-00433-9

BibTeX
@article{vanLeeuwaarde2025,
  author = {van Leeuwaarde, Rachel S and Halfdanarson, Thorvardur R and Sudhakar, Shwetha M and Meijers, Ruud W J and Folpe, Andrew L and Brosens, Lodewijk A A},
  title = {Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression},
  journal = {Familial Cancer},
  year = {2025},
  volume = {24},
  number = {1},
  doi = {10.1007/s10689-024-00433-9}
}
Kostenlos starten →